Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mucopolysaccharidosis VII Disease Monitoring Program (MPS VII DMP)

NCT03604835 is registered in ClinicalTrials.gov with Ultragenyx Pharmaceutical Inc as lead sponsor.

NCT NCT03604835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03604835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mucopolysaccharidosis VII Disease Monitoring Program (MPS VII DMP)
Lead sponsor
Ultragenyx Pharmaceutical Inc
Phase
Observational
Overall status
Recruiting
Start date
January 29, 2018
Completion date
April 30, 2032
Enrollment
50 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

mps 7, mps vii, mucopolysaccharidosis vii, sly syndrome